Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSULA intranasal insulin study in early Alzheimer's disease and type 2 diabetes-related cognitive impairment
2008-008555-41Phase 2Terminated
- Sponsor
- Universitätsmedizin Essen
- Start
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of insulin aspart in Alzheimer's disease (AD), type 2 diabetes mellitus (T2DM) and Mild Cognitive Impairment (MCI) (2 arms), sponsored by Universitätsmedizin Essen. Primary endpoint: Change in delayed recall. Started Aug 2010; status: terminated.
02
Drugs
insulin aspart
03
Conditions
Alzheimer's disease (AD)type 2 diabetes mellitus (T2DM)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on 2008-008555-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008555-41.